The National Cancer Institute awarded a $10,654,356.68 definitive contract to Elekta Inc. for acquisition and installation of a magnetic resonance linear accelerator system for radiation therapy on September 24, 2026, under a firm fixed-price structure with no set-aside.
Place of performance includes the NIH Clinical Center, NCI Radiation Oncology Branch in Bethesda, Maryland, with manufacturing, staging, and pre-installation planning at Elekta's facility. The originating solicitation called for an integrated 1.5 Tesla MR imaging scanner with a 7 megavolt photon beam linear accelerator equipped with a 160 leaf multi-leaf collimator, online adaptive planning system with server and treatment planning workstation, quality assurance phantoms and software, patient positioning system, and ancillary equipment. The contract includes site planning, shielding and integration support, delivery, OEM-certified installation, commissioning, onsite training, and a minimum 12-month warranty covering all parts, materials, labor, and travel. Performance runs from September 28, 2026 through September 24, 2027. NAICS 339112 (Surgical and Medical Instrument Manufacturing) applies with a 1,000-employee size standard.